JP2018534919A - L−メチオニンの製造方法 - Google Patents
L−メチオニンの製造方法 Download PDFInfo
- Publication number
- JP2018534919A JP2018534919A JP2018516701A JP2018516701A JP2018534919A JP 2018534919 A JP2018534919 A JP 2018534919A JP 2018516701 A JP2018516701 A JP 2018516701A JP 2018516701 A JP2018516701 A JP 2018516701A JP 2018534919 A JP2018534919 A JP 2018534919A
- Authority
- JP
- Japan
- Prior art keywords
- methionine
- methyl mercaptan
- dmds
- thiol group
- precursor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 title claims abstract description 86
- 229960004452 methionine Drugs 0.000 title claims abstract description 86
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 title claims abstract description 74
- 229930195722 L-methionine Natural products 0.000 title claims abstract description 74
- 238000004519 manufacturing process Methods 0.000 title abstract description 7
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 claims abstract description 140
- 239000002243 precursor Substances 0.000 claims abstract description 34
- 238000006911 enzymatic reaction Methods 0.000 claims abstract description 8
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 claims description 129
- 238000000034 method Methods 0.000 claims description 64
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 48
- 102000004190 Enzymes Human genes 0.000 claims description 42
- 108090000790 Enzymes Proteins 0.000 claims description 42
- 230000015572 biosynthetic process Effects 0.000 claims description 41
- 238000003786 synthesis reaction Methods 0.000 claims description 36
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 32
- 150000001875 compounds Chemical class 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 29
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 27
- 235000012209 glucono delta-lactone Nutrition 0.000 claims description 25
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims description 24
- 108010024636 Glutathione Proteins 0.000 claims description 24
- 229960003681 gluconolactone Drugs 0.000 claims description 24
- 229960003180 glutathione Drugs 0.000 claims description 24
- 230000003197 catalytic effect Effects 0.000 claims description 23
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 22
- 239000008103 glucose Substances 0.000 claims description 22
- 230000008569 process Effects 0.000 claims description 22
- 235000001014 amino acid Nutrition 0.000 claims description 21
- 150000001413 amino acids Chemical class 0.000 claims description 21
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 21
- 238000006722 reduction reaction Methods 0.000 claims description 20
- 230000009467 reduction Effects 0.000 claims description 17
- FCXZBWSIAGGPCB-YFKPBYRVSA-N O-acetyl-L-homoserine Chemical group CC(=O)OCC[C@H]([NH3+])C([O-])=O FCXZBWSIAGGPCB-YFKPBYRVSA-N 0.000 claims description 15
- 102000004316 Oxidoreductases Human genes 0.000 claims description 15
- 108090000854 Oxidoreductases Proteins 0.000 claims description 15
- 230000002255 enzymatic effect Effects 0.000 claims description 14
- 101710088194 Dehydrogenase Proteins 0.000 claims description 12
- 229930182817 methionine Natural products 0.000 claims description 12
- 238000000855 fermentation Methods 0.000 claims description 11
- 230000004151 fermentation Effects 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 7
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims description 5
- 238000006356 dehydrogenation reaction Methods 0.000 claims description 5
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 4
- 235000018417 cysteine Nutrition 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 238000011084 recovery Methods 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 claims description 3
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 claims description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 3
- 102000002933 Thioredoxin Human genes 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 108060008226 thioredoxin Proteins 0.000 claims description 3
- 229940094937 thioredoxin Drugs 0.000 claims description 3
- GNISQJGXJIDKDJ-YFKPBYRVSA-N O-succinyl-L-homoserine Chemical compound OC(=O)[C@@H](N)CCOC(=O)CCC(O)=O GNISQJGXJIDKDJ-YFKPBYRVSA-N 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 125000002228 disulfide group Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 238000010952 in-situ formation Methods 0.000 claims description 2
- 229920005862 polyol Polymers 0.000 claims description 2
- 150000003077 polyols Chemical class 0.000 claims description 2
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 150000002894 organic compounds Chemical class 0.000 abstract description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 16
- 239000012429 reaction media Substances 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 108010063907 Glutathione Reductase Proteins 0.000 description 10
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 9
- 239000001257 hydrogen Substances 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 238000005580 one pot reaction Methods 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical group OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 5
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 5
- 229960001327 pyridoxal phosphate Drugs 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- 108010053070 Glutathione Disulfide Proteins 0.000 description 4
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 150000002019 disulfides Chemical class 0.000 description 4
- 229940045883 glutathione disulfide Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 3
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 3
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 3
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 3
- 239000000174 gluconic acid Substances 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 239000000852 hydrogen donor Substances 0.000 description 3
- 238000007327 hydrogenolysis reaction Methods 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 238000010907 mechanical stirring Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- 108700035987 EC 1.6.4.2 Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 description 2
- 108010079911 Thioredoxin-disulfide reductase Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- 229960002715 nicotine Drugs 0.000 description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- -1 transition metal sulfides Chemical class 0.000 description 2
- IVWWFWFVSWOTLP-YVZVNANGSA-N (3'as,4r,7'as)-2,2,2',2'-tetramethylspiro[1,3-dioxolane-4,6'-4,7a-dihydro-3ah-[1,3]dioxolo[4,5-c]pyran]-7'-one Chemical compound C([C@@H]1OC(O[C@@H]1C1=O)(C)C)O[C@]21COC(C)(C)O2 IVWWFWFVSWOTLP-YVZVNANGSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- IJOJIVNDFQSGAB-SQOUGZDYSA-N 6-O-phosphono-D-glucono-1,5-lactone Chemical compound O[C@H]1[C@H](O)[C@@H](COP(O)(O)=O)OC(=O)[C@@H]1O IJOJIVNDFQSGAB-SQOUGZDYSA-N 0.000 description 1
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010026373 Cystine reductase Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 150000008546 L-methionines Chemical class 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- 101710198496 O-acetyl-L-homoserine sulfhydrylase Proteins 0.000 description 1
- 108010061618 O-succinylhomoserine (thiol)-lyase Proteins 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000019730 animal feed additive Nutrition 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000002152 aqueous-organic solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 239000000386 donor Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000182 glucono-delta-lactone Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 230000006372 lipid accumulation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002741 methionine derivatives Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229940101270 nicotinamide adenine dinucleotide (nad) Drugs 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000008823 permeabilization Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000066 reactive distillation Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000001577 simple distillation Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- SRRKNRDXURUMPP-UHFFFAOYSA-N sodium disulfide Chemical compound [Na+].[Na+].[S-][S-] SRRKNRDXURUMPP-UHFFFAOYSA-N 0.000 description 1
- RMBAVIFYHOYIFM-UHFFFAOYSA-M sodium methanethiolate Chemical compound [Na+].[S-]C RMBAVIFYHOYIFM-UHFFFAOYSA-M 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000001991 steam methane reforming Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/12—Methionine; Cysteine; Cystine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0051—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01047—Glucose 1-dehydrogenase (1.1.1.47)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
- C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
- C12Y108/01009—Thioredoxin-disulfide reductase (1.8.1.9), i.e. thioredoxin-reductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y112/00—Oxidoreductases acting on hydrogen as donor (1.12)
- C12Y112/01—Oxidoreductases acting on hydrogen as donor (1.12) with NAD+ or NADP+ as acceptor (1.12.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01049—O-acetylhomoserine aminocarboxypropyltransferase (2.5.1.49)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
- C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
- C12Y108/01007—Glutathione-disulfide reductase (1.8.1.7), i.e. glutathione reductase (NADPH)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
a)
1)ジメチルジスルフィド(DMDS)、
2)触媒量の、チオール基を有するアミノ酸またはチオール基含有ペプチド、
3)触媒量の、前記チオール基を有するアミノ酸または前記チオール基含有ペプチドのジスルフィド架橋の還元反応を触媒する酵素、
4)ジスルフィド、特にDMDSに対して化学量論量の有機還元化合物、
5)触媒量の、当該有機還元化合物の脱水素反応を触媒する酵素、
6)触媒量の、触媒系の2種の酵素(デヒドロゲナーゼおよびレダクターゼ)に共通の補因子
を含む混合物を調製するステップ、
b)メチルメルカプタン(CH3−SH)を形成するための酵素反応を行うステップ、
c)L−メチオニンの前駆体を添加し、ステップb)で形成されたメチルメルカプタンを用いて前記前駆体を変換するステップ、および
d)形成されたL−メチオニンを回収し、任意選択で精製するステップ
を含む方法である。
a’)
・ジメチルジスルフィド(DMDS)、
・触媒量の、チオール基を有するアミノ酸またはチオール基含有ペプチド、
・触媒量の、前記チオール基を有するアミノ酸または前記チオール基含有ペプチドに対応するレダクターゼ酵素、
・触媒量のNADPH
を含む混合物を調製するステップ、
b’)ジメチルジスルフィド)に対して化学量論量の有機還元化合物を、触媒量の対応するデヒドロゲナーゼ酵素と共に添加するステップ、
c’)メチルメルカプタン(CH3−SH)を形成するための酵素反応を行うステップ、
d’)ステップc’)で形成されたメチルメルカプタンによってL−メチオニン前駆体を変換するステップ、および
e’)形成されたL−メチオニンを回収し、任意選択で精製するステップ
を含む。
ステップ1:例えばグルコースの細菌発酵によるL−メチオニン前駆体の調製(WO2008013432および/またはWO2013029690を参照のこと。)、
ステップ2:前記反応装置R1から離脱するメチルメルカプタンの形成を伴う、反応装置R1におけるDMDSの酵素還元(上記のステップa’)からc’)に相当)、
ステップ3:ステップ1からの前駆体およびステップ2からのメチルメルカプタンを用いた反応装置R2におけるL−メチオニンを酵素合成(上記ステップd’に相当)、
ステップ4(任意選択):ステップ3で形成されたグルコノラクトンのステップ1への再循環、
ステップ5:形成されたL−メチオニンの回収および任意選択の精製(上記のステップe’に対応)
を含む。
ステップ1’:例えば、グルコースの細菌発酵によるL−メチオニン前駆体の調製(上記のステップ1と同様)、
ステップ2’:メチルメルカプタンのインサイチュー形成およびこれと同時の同じ反応装置中におけるステップ1’で得た前駆体によるL−メチオニンの酵素合成を伴う、反応装置R1におけるDMDSの酵素還元、
ステップ3’(任意選択):ステップ2’で形成したグルコノラクトンのステップ1’への再循環、
ステップ4’:形成されたL−メチオニンの回収および任意選択の精製
を含む。
2連続ステップ
グルタチオン酵素複合体(Aldrich)10mlおよびグルコース19.2g(0.1mol)を、pH7.30の0.1mol/lリン酸緩衝液150mlを含有する反応装置R1に導入する。酵素複合体の溶液は、グルタチオン185mg(0.6mmol)、グルタチオンレダクターゼ200U、NADPH 50mg(0.06mmol)およびグルコースデヒドロゲナーゼ200Uを含有する。反応媒体を機械撹拌しながら25℃とする。第1のサンプルをt=0にて採取する。続いて、ジメチルジスルフィド(9.4g、0.1mol)をビュレットに入れ、反応装置に滴加すると、反応が開始する。窒素流を反応装置に導入する。
「ワンポット」法
酵素複合体10ml、グルコース6g(33mmol)およびO−アセチル−L−ホモセリン5g(31mmol)(OAHS、O−アセチル−L−ホモセリンは、Sadamu Nagai,「Synthesis of O−acetyl−l−homoserine」,Academic Press,(1971),vol.17,pp.423−424に従って、L−ホモセリンと無水酢酸から合成した。)をpH7の0.2mol.l−1リン酸緩衝液150mlを含有する反応装置に導入する。酵素複合体の溶液は、グルタチオン185mg(0.6mmol)、グルタチオンレダクターゼ200U、NADPH 50mg(0.06mmol)、グルコースデヒドロゲナーゼ200U、ピリドキサールホスフェート0.4g(1.6mmol)およびO−アセチル−L−ホモセリンスルフヒドリラーゼ0.6gを含有する。
Claims (15)
- L−メチオニンの調製方法であって、少なくとも:
a)
1)ジメチルジスルフィド(DMDS)、
2)触媒量の、チオール基を有するアミノ酸またはチオール基含有ペプチド、
3)触媒量の、前記チオール基を有するアミノ酸または前記チオール基含有ペプチドのジスルフィド架橋の還元反応を触媒する酵素、
4)前記ジスルフィド、特に前記DMDSに対して化学量論量の有機還元化合物、
5)触媒量の、当該有機還元化合物の脱水素反応を触媒する酵素、
6)触媒量の、触媒系の2種の酵素(デヒドロゲナーゼおよびレダクターゼ)に共通の補因子
を含む混合物を調製するステップ、
b)メチルメルカプタン(CH3−SH)を形成するための酵素反応を行うステップ、
c)L−メチオニンの前駆体を添加し、ステップb)で形成された前記メチルメルカプタンを用いて前記前駆体を変換するステップ、および
d)形成された前記L−メチオニンを回収し、任意選択で精製するステップ
を含む方法。 - 少なくとも以下の:
a’)
・ジメチルジスルフィド(DMDS)、
・触媒量の、チオール基を有するアミノ酸またはチオール基含有ペプチド、
・触媒量の、前記チオール基を有するアミノ酸または前記チオール基含有ペプチドに対応するレダクターゼ酵素、
・触媒量のNADPH
を含む混合物を調製するステップ、
b’)前記ジメチルジスルフィド)に対して化学量論量の有機還元化合物を、触媒量の対応するデヒドロゲナーゼ酵素と共に添加するステップ、
c’)メチルメルカプタン(CH3−SH)を形成するための酵素反応を行うステップ、
d’)ステップc’)で形成された前記メチルメルカプタンによってL−メチオニン前駆体を変換するステップ、および
e’)形成された前記L−メチオニンを回収し、任意選択で精製するステップ
を含む、請求項1に記載の方法。 - 前記メチルメルカプタンがメチオニン前駆体と接触して直接配置される、請求項1または2に記載の方法。
- 前記有機還元化合物が、アルコール、ポリオール、糖類などから選択される、ヒドロキシル官能基を有する水素供与性有機還元化合物である、請求項1から3のいずれか一項に記載の方法。
- 前記有機還元化合物が、グルコース、グルコース6−ホスフェートおよびイソプロパノールから選択される、請求項1から4のいずれか一項に記載の方法。
- 前記チオール基を有するアミノ酸または前記チオール基を有するペプチドが、システイン、ホモシステイン、グルタチオンおよびチオレドキシンから選択される、請求項1から5のいずれか一項に記載の方法。
- 前記L−メチオニン前駆体が、O−アセチル−L−ホモセリンおよびO−スクシニル−L−ホモセリンから選択される、請求項1から6のいずれか一項に記載の方法。
- 前記メチルメルカプタンが、反応装置を離脱する際に、L−メチオニンの合成で直接使用される、請求項1から7のいずれか一項に記載の方法。
- 少なくとも以下のステップ:
ステップ1:例えばグルコースの細菌発酵によるL−メチオニン前駆体の調製、
ステップ2:前記反応装置R1から離脱するメチルメルカプタンの形成を伴う、反応装置R1におけるDMDSの酵素還元、
ステップ3:ステップ1からの前記前駆体およびステップ2からの前記メチルメルカプタンを用いた反応装置R2におけるL−メチオニンを酵素合成、
ステップ4(任意選択):ステップ3で形成されたグルコノラクトンのステップ1への再循環、
ステップ5:形成された前記L−メチオニンの回収および任意選択の精製
を含む請求項8に記載の方法。 - DMDSからのメチルメルカプタンの合成および前記メチルメルカプタンからのL−メチオニンの合成が同一の反応装置中で行われる、請求項1から7のいずれか一項に記載の方法。
- 少なくとも以下のステップ:
ステップ1’:グルコースの細菌発酵によるL−メチオニン前駆体の調製、
ステップ2’:メチルメルカプタンのインサイチュー形成およびこれと同時の同じ反応装置中におけるステップ1’で得た前記前駆体によるL−メチオニンの酵素合成を伴う、反応装置R1におけるDMDSの酵素還元、
ステップ3’(任意選択):ステップ2’で形成したグルコノラクトンのステップ1’への再循環、
ステップ4’:形成された前記L−メチオニンの回収および任意選択の精製
を含む請求項10に記載の方法。 - バッチ式でまたは連続的に実施される、請求項1から11のいずれか一項に記載の方法。
- 理想的な有機還元化合物/DMDSモル比が0.01から100まで変化し、好ましくは前記モル比が0.5から5から選択され、および全く好ましくは前記モル比が1に等しい、請求項1から12のいずれか一項に記載の方法。
- DMDS/L−メチオニン前駆体のモル比が、0.1から10、一般に0.5から5であり、好ましくは前記モル比が化学量論(モル比=0.5)である、請求項1から13のいずれか一項に記載の方法。
- 反応温度が、10℃から50℃、好ましくは15℃から45℃、より好ましくは20℃から40℃の範囲である、請求項1から14のいずれか一項に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1559273 | 2015-09-30 | ||
FR1559273A FR3041658B1 (fr) | 2015-09-30 | 2015-09-30 | Procede de production de l-methionine |
PCT/FR2016/052481 WO2017055754A1 (fr) | 2015-09-30 | 2016-09-29 | Procédé de production de l-méthionine |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018534919A true JP2018534919A (ja) | 2018-11-29 |
JP6790083B2 JP6790083B2 (ja) | 2020-11-25 |
Family
ID=54979758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018516701A Active JP6790083B2 (ja) | 2015-09-30 | 2016-09-29 | L−メチオニンの製造方法 |
Country Status (17)
Country | Link |
---|---|
US (1) | US10563235B2 (ja) |
EP (1) | EP3356540B1 (ja) |
JP (1) | JP6790083B2 (ja) |
KR (1) | KR102078490B1 (ja) |
CN (1) | CN108026550B (ja) |
DK (1) | DK3356540T3 (ja) |
ES (1) | ES2804874T3 (ja) |
FR (1) | FR3041658B1 (ja) |
HU (1) | HUE049907T2 (ja) |
LT (1) | LT3356540T (ja) |
MY (1) | MY183681A (ja) |
PL (1) | PL3356540T3 (ja) |
RU (1) | RU2711353C1 (ja) |
SA (1) | SA518391161B1 (ja) |
SG (1) | SG11201802624YA (ja) |
SI (1) | SI3356540T1 (ja) |
WO (1) | WO2017055754A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2023517686A (ja) * | 2020-03-09 | 2023-04-26 | アルケマ フランス | ジスルフィド及びスルホキシド又はスルホンの共生成のための化学酵素プロセス |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3041659B1 (fr) * | 2015-09-30 | 2017-10-20 | Arkema France | Procede de production de l-methionine |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07503855A (ja) * | 1992-02-20 | 1995-04-27 | ジェネンコア インターナショナル インコーポレーテッド | 硫黄の還元源を用いたメチオニンの生合成 |
JPH07304730A (ja) * | 1993-10-20 | 1995-11-21 | Elf Aquitaine Prod | 二硫化ジメチルからのメチルメルカプタンの合成 |
US20050260250A1 (en) * | 2004-05-24 | 2005-11-24 | Ott David M | Medicinal products incorporating bound organosulfur groups |
JP2014521358A (ja) * | 2011-09-02 | 2014-08-28 | アルケマ フランス | L−メチオニンの製造方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3636098A (en) | 1966-07-02 | 1972-01-18 | Sumitomo Chemical Co | Process for producing methionine |
US4059636A (en) | 1976-05-04 | 1977-11-22 | Phillips Petroleum Company | Mercaptans by catalytic cleavage of organic sulfides |
JPS6013668B2 (ja) | 1980-09-25 | 1985-04-09 | 協和醗酵工業株式会社 | グルタチオン・パ−オキシダ−ゼの製造法 |
DE4235295A1 (de) | 1992-10-20 | 1994-04-21 | Degussa | Kontinuierlich durchführbares Verfahren zur Herstellung von Methionin oder Methioninderivaten |
DE19547236A1 (de) | 1995-12-18 | 1997-07-03 | Degussa | Verfahren zur Herstellung von D,L-Methionin oder dessen Salz |
WO2005107723A2 (en) | 2004-05-06 | 2005-11-17 | Rashid Buttar | Transdermal delivery systems and transdermal chelation preparations |
CA2615315C (en) * | 2005-07-18 | 2015-10-06 | Basf Aktiengesellschaft | Use of dimethyl disulfide for methionine production in microorganisms |
BRPI0620880B1 (pt) | 2006-01-04 | 2018-10-09 | Evonik Degussa Gmbh | método para a produção de metionina, pelo cultivo de um microorganismo, e, microorganismo |
WO2008006977A1 (fr) | 2006-07-11 | 2008-01-17 | Adisseo France S.A.S. | Procédé de préparation du 2-hydroxy-4-(méthylthio)butyronitrile et de la méthionine |
FR2903690B1 (fr) | 2006-07-11 | 2008-11-14 | Adisseo Ireland Ltd | Procede de preparation de la methionine a partir d'acroleine sans isoler de produits intermediaires |
KR100905381B1 (ko) * | 2006-07-28 | 2009-06-30 | 씨제이제일제당 (주) | L-메치오닌 전구체 생산 균주 및 상기 l-메치오닌전구체로부터의 l-메치오닌 및 유기산의 생산방법 |
MX2009001816A (es) | 2006-08-24 | 2009-05-28 | Evonik Degussa Gmbh | Procedimiento para la produccion de acido d,l-2-hidroxi-4-alquilti o butirico. |
WO2009043372A1 (en) | 2007-10-02 | 2009-04-09 | Metabolic Explorer | Increasing methionine yield |
DE102008038501A1 (de) | 2008-08-20 | 2010-02-25 | Endress + Hauser Gmbh + Co. Kg | Verfahren zum Bestimmen einer statischen Datenstruktur eines Feldgerätes |
WO2010020290A1 (en) | 2008-08-22 | 2010-02-25 | Metabolic Explorer | Producing methionine without n-acetyl methionine |
KR101048593B1 (ko) * | 2009-02-27 | 2011-07-12 | 씨제이제일제당 (주) | 메칠머캅탄과 디메칠설파이드의 혼합물을 사용하여 메치오닌 생산능을 증가시키는 방법 |
FR2994974B1 (fr) | 2012-08-30 | 2015-05-01 | Arkema France | Distillation reactive des dso |
CN103053703B (zh) | 2013-01-18 | 2014-06-04 | 岑溪市信畅坚果开发有限公司 | 澳洲坚果豆腐的制作方法 |
FR3041659B1 (fr) * | 2015-09-30 | 2017-10-20 | Arkema France | Procede de production de l-methionine |
-
2015
- 2015-09-30 FR FR1559273A patent/FR3041658B1/fr active Active
-
2016
- 2016-09-29 EP EP16785252.4A patent/EP3356540B1/fr active Active
- 2016-09-29 SG SG11201802624YA patent/SG11201802624YA/en unknown
- 2016-09-29 WO PCT/FR2016/052481 patent/WO2017055754A1/fr active Application Filing
- 2016-09-29 CN CN201680056950.3A patent/CN108026550B/zh active Active
- 2016-09-29 JP JP2018516701A patent/JP6790083B2/ja active Active
- 2016-09-29 KR KR1020187011409A patent/KR102078490B1/ko active IP Right Grant
- 2016-09-29 DK DK16785252.4T patent/DK3356540T3/da active
- 2016-09-29 HU HUE16785252A patent/HUE049907T2/hu unknown
- 2016-09-29 ES ES16785252T patent/ES2804874T3/es active Active
- 2016-09-29 MY MYPI2018701239A patent/MY183681A/en unknown
- 2016-09-29 LT LTEP16785252.4T patent/LT3356540T/lt unknown
- 2016-09-29 RU RU2018114021A patent/RU2711353C1/ru active
- 2016-09-29 PL PL16785252T patent/PL3356540T3/pl unknown
- 2016-09-29 SI SI201630850T patent/SI3356540T1/sl unknown
- 2016-09-29 US US15/763,799 patent/US10563235B2/en active Active
-
2018
- 2018-03-21 SA SA518391161A patent/SA518391161B1/ar unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07503855A (ja) * | 1992-02-20 | 1995-04-27 | ジェネンコア インターナショナル インコーポレーテッド | 硫黄の還元源を用いたメチオニンの生合成 |
JPH07304730A (ja) * | 1993-10-20 | 1995-11-21 | Elf Aquitaine Prod | 二硫化ジメチルからのメチルメルカプタンの合成 |
US20050260250A1 (en) * | 2004-05-24 | 2005-11-24 | Ott David M | Medicinal products incorporating bound organosulfur groups |
JP2014521358A (ja) * | 2011-09-02 | 2014-08-28 | アルケマ フランス | L−メチオニンの製造方法 |
Non-Patent Citations (2)
Title |
---|
J. ORG. CHEM., vol. 57, JPN6019018982, 1992, pages 123 - 127, ISSN: 0004041925 * |
J. ORG. CHEM., vol. 58, JPN6019018983, 1993, pages 4144 - 4146, ISSN: 0004041926 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2023517686A (ja) * | 2020-03-09 | 2023-04-26 | アルケマ フランス | ジスルフィド及びスルホキシド又はスルホンの共生成のための化学酵素プロセス |
Also Published As
Publication number | Publication date |
---|---|
US20180291408A1 (en) | 2018-10-11 |
EP3356540A1 (fr) | 2018-08-08 |
PL3356540T3 (pl) | 2020-09-07 |
EP3356540B1 (fr) | 2020-06-03 |
WO2017055754A1 (fr) | 2017-04-06 |
LT3356540T (lt) | 2020-08-10 |
KR102078490B1 (ko) | 2020-02-17 |
DK3356540T3 (da) | 2020-07-27 |
MY183681A (en) | 2021-03-08 |
SI3356540T1 (sl) | 2020-08-31 |
HUE049907T2 (hu) | 2020-11-30 |
KR20180055887A (ko) | 2018-05-25 |
SA518391161B1 (ar) | 2021-05-18 |
CN108026550A (zh) | 2018-05-11 |
US10563235B2 (en) | 2020-02-18 |
FR3041658B1 (fr) | 2017-10-20 |
SG11201802624YA (en) | 2018-04-27 |
ES2804874T3 (es) | 2021-02-09 |
FR3041658A1 (fr) | 2017-03-31 |
JP6790083B2 (ja) | 2020-11-25 |
CN108026550B (zh) | 2022-10-04 |
RU2711353C1 (ru) | 2020-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Andreesen | Glycine reductase mechanism | |
US20220372530A1 (en) | Method for producing mercaptans by disulfide enzyme hydrogenolysis | |
JP6790083B2 (ja) | L−メチオニンの製造方法 | |
JP6742404B2 (ja) | L−メチオニンの製造方法 | |
RU2720091C1 (ru) | Способ получения меркаптанов путем ферментативного гидрогенолиза дисульфидов с помощью водорода | |
BR112018005252B1 (pt) | Método de produção de l-metionina | |
BR112018005656B1 (pt) | Método de produção de l-metionina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180529 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180529 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190528 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190822 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191101 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200421 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200820 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20200820 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200824 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20200911 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20200915 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201020 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201104 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6790083 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |